A Continuous Subcutaneous Insulin Infusion Needle Break

Le résumé fourni par la source

### Adverse Event Our patient was 13 years and 2 months old, a white boy with type 1 diabetes diagnosed 2 years and 5 months before this adverse event (AE). He had no other significant medical history. His A1C was 7.6% 1 month before the insulin infusion needle break event. The patient had started on the t-slim insulin pump (Tandem Diabetes Care, San Diego, Calif.) 1 year and 6 days before the AE occurred. He was using the contact Detach (Unomedical, Inc., Bridgewater, N.J.) infusion set and lispro insulin. The contact Detach infusion set features a very fine, 29-gauge, 90° steel needle. With its additional adhesive pad, contact Detach provides extra security against needle dislodging. Its simplicity and security make it a good choice for active young children, pregnant women, and adults for whom soft cannula sets do not work well. The contact Detach set is available in 6- and 8-mm needle lengths and 23- and 32-inch tubing lengths (1). There were no reported previous pump AEs, emergency department visits, or diabetes ketoacidosis episodes related to continuous subcutaneous insulin infusion (CSII) therapy. The patient’s BMI was 18.65 kg/m2. The patient’s mother reported changing the pump site, per usual, on 16 July 2014. When she went to remove the infusion set, the needle was not attached to it. The parents could not find the needle. The patient did not feel any pain or discomfort where the infusion set had been placed. At the time the 8-mm needle broke off from the infusion site, it had been placed on the upper left buttock area at a 90° angle with IV3000 1-HAND adhesive dressing (Smith & …

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.